23andMe's new G6PD Deficiency* report provides information on whether a customer has a variant called Val68Met, which can lead to defects in an enzyme called glucose-6-phosphate dehydrogenase, or G6PD, that is associated with a form of anemia.

People chronically infected with the hepatitis C virus currently have only one treatment option:   a combination of polyethylene glycol (PEG)-ylated interferon alpha and ribavirin (RBV).    Not only does...